Patent · US Active

Modulators of TNF-α signaling

US9579325B2 · kind B2 · utility

0Cited by
41References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 25, 2014
Grant dateFeb 28, 2017
Priority date
Expiry dateNov 25, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.